Word

TINOS THERAPEUTICS

Status

Pending

Status Code

681

Status Date

Tuesday, August 27, 2024

Serial Number

97914745

Mark Type

4

Filing Date

Monday, May 1, 2023

Published for Opposition

Tuesday, October 1, 2024

Trademark Owner History

Tinos Therapeutics, Inc.

Classifications

5 pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)

"THERAPEUTICS"
The wording TINOS has no meaning in a foreign language.

Trademark Events

May 4, 2023

New Application Entered

Apr 24, 2024

Application Extension To Response Period - Received

Apr 24, 2024

Application Extension Granted/Receipt Provided

May 30, 2023

New Application Office Supplied Data Entered

Jan 26, 2024

Assigned To Examiner

Feb 7, 2024

Non-Final Action Written

Feb 7, 2024

Non-Final Action E-Mailed

Feb 7, 2024

Notification Of Non-Final Action E-Mailed

Jul 18, 2024

Correspondence Received In Law Office

Jul 18, 2024

Teas/Email Correspondence Entered

Jul 18, 2024

Teas Response To Office Action Received

Aug 26, 2024

Approved For Pub - Principal Register

Sep 11, 2024

Notification Of Notice Of Publication E-Mailed